Clinical Trials
3 trialsNCT03429101 2021-01-15
A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer
Spectrum Pharmaceuticals, Inc
Phase 1 Terminated
NCT01455571 2014-02-26
Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors
Hanmi Pharmaceutical Company Limited
Phase 1 Completed
NCT01455584 2013-05-23
Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors
Hanmi Pharmaceutical Company Limited
Phase 1 Completed